AQST | Aquestive TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$3.77
-$0.12 (-3.08%)

Aquestive Therapeutics (AQST) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Sep 2026, and the two have been drifting apart, yet a death cross is projected within 30 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Weekly as of 30 Oct 16:00 ET

Price
between the two $3.89 vs 50 $4.42 / 200 $3.39
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 26 Aug 2024 ยท projected 26 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $3.86 vs 50 $4.29 / 200 $4.41
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Death cross 28 Oct 2026 ยท projected 21 bars out

Cross history

26
crosses on record since 2019
14 golden12 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
28 Oct 2026Death4-hour21 bars outActive Cross Test
18 Sep 2026Golden moderatedaily23 bars outNot tested
27 Aug 2026Golden4-hour27 bars outNot tested
28 Jul 2026Death4-hour18 bars outNot tested
19 May 2026Golden4-hour30 bars out7 bar cross test

About AQST

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$10.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.